Partnership with Pictor Labs brings H&E, IHC, and special stains to Concentriq software, aiming to reduce costs and improve workflow efficiency.
Proscia has integrated virtual staining capabilities into its Concentriq software platform through a partnership with Pictor Labs, aiming to help laboratories reduce costs associated with traditional chemical staining methods while improving efficiency in high-throughput workflows.
The virtual staining technology uses AI models to replicate the effects of stains on tissue images, generating whole-slide virtually stained images from label-free inputs in minutes compared to the hours or days required for conventional methods.
“With Pictor Labs powering virtual staining on Concentriq, teams can generate H&E, IHC, and special stains on-demand and review results in minutes instead of hours or days, turning scarce tissue into more valuable samples without re-cuts or chemicals,” says Yair Rivenson, CEO of Pictor Labs, in a release.
Addressing Traditional Staining Limitations
Conventional staining with chemical reagents is a critical step in producing data-rich images for digital pathology, but the process presents several challenges. Traditional methods are costly, slow, and tissue-destructive, and inconsistency can make it difficult to achieve reproducible results, according to Proscia.
The virtual staining integration extends workflows already used by more than 12,000 pathologists and scientists worldwide and expands the platform’s precision medicine AI portfolio. The AI-generated stains are designed to open new possibilities, including lower-cost avenues for biomarker exploration and multiplex assay development.
“Virtual staining is a powerful example of the growing impact of pathology AI,” says David West, CEO of Proscia, in a release. “By introducing it in Concentriq, we are reinforcing our commitment to helping our customers leverage AI across every dimension of their work.”
Technology and Partnership Details
Proscia will integrate a menu of H&E, IHC, and special stains into Concentriq. The virtual staining is powered by Pictor Labs’ DeepStain and ReStain technologies, which enable unlimited virtual staining from a single tissue sample.
As part of the partnership, Pictor Labs will join the Proscia Ready partner alliance, which comprises solution providers helping life sciences organizations and diagnostic laboratories accelerate digital pathology adoption.
The virtual staining technology is currently for research use only and has not been cleared or approved by the US Food and Drug Administration.
Photo caption: Concentriq AP platform
Photo credit: Proscia/File Photo
